AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium.
Publication/Presentation Date
6-9-2020
Volume
22
Issue
6
First Page
886
Last Page
888
ISSN
1523-5866
Published In/Presented At
Davatzikos, C., Barnholtz-Sloan, J. S., Bakas, S., Colen, R., Mahajan, A., Quintero, C. B., Capellades Font, J., Puig, J., Jain, R., Sloan, A. E., Badve, C., Marcus, D. S., Seong Choi, Y., Lee, S. K., Chang, J. H., Poisson, L. M., Griffith, B., Dicker, A. P., Flanders, A. E., Booth, T. C., … O'Rourke, D. M. (2020). AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium. Neuro-oncology, 22(6), 886–888. https://doi.org/10.1093/neuonc/noaa045
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
32152622
Department(s)
Administration and Leadership
Document Type
Article
COinS